Introduction: Doxycycline is highly effective, inexpensive with a broad therapeutic spectrum and exceptional bioavailability. However these benefits have been overshadowed by its classification alongside the tetracyclines - class D drugs, contraindicated in pregnancy and in children under 8 years of age. Doxycycline-treatable diseases are emerging as leading causes of undifferentiated febrile illness in Southeast Asia. For example scrub typhus and murine typhus have an unusually severe impact...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's version
- Taylor & Francis Publisher's website
- Expert Opinion On Drug Safety Journal website
- Publication date:
1474-0338 and 1744-764X
- Pubs id:
- Local pid:
- Copyright holder:
- © 2016 The Author(s).
- Copyright date:
© 2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Revisiting doxycycline in pregnancy and early childhood - time to rebuild its reputation?
If you are the owner of this record, you can report an update to it here: Report update to this record